Seth, R. K., Das, S., Dattaroy, D., Chandrashekaran, V., Alhasson, F., Michelotti, G., . . . Chatterjee, S. (2016). TRPV4 activation of endothelial nitric oxide synthase resists nonalcoholic fatty liver disease by blocking CYP2E1-mediated redox toxicity. Free Radic Biol Med.
استشهاد بنمط شيكاغوSeth, Ratanesh K., et al. "TRPV4 Activation of Endothelial Nitric Oxide Synthase Resists Nonalcoholic Fatty Liver Disease By Blocking CYP2E1-mediated Redox Toxicity." Free Radic Biol Med 2016.
MLA استشهادSeth, Ratanesh K., et al. "TRPV4 Activation of Endothelial Nitric Oxide Synthase Resists Nonalcoholic Fatty Liver Disease By Blocking CYP2E1-mediated Redox Toxicity." Free Radic Biol Med 2016.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.